Question 1

What are the factors influencing the U.S. dermal toxicity testing industry?

Accepted Answer

U.S. dermal toxicity testing market accounted for over USD 1.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to an increased emphasis on alternatives to traditional animal testing methods.

Question 2

Who are the key players in the global dermal toxicity testing industry?

Accepted Answer

QIMA LTD, Charles River Laboratories, Evotec, MatTek Corporation, Eurofins Scientific, SGS Group, Intertek Group, InVivo Biosystems, Eurofins Scientific, and Qiagen N.V.

Question 3

How big is the dermal toxicity testing market?

Accepted Answer

The dermal toxicity testing industry was valued at USD 2.1 billion in 2022 and is estimated to reach USD 4.5 billion by 2032 as there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures.

Question 4

Why is in-vitro testing method gaining traction in the dermal toxicity testing industry?

Accepted Answer

The in-vitro testing segment had a market share of over 42% in 2022 and will grow through 2032 due to advancements in cell culture technologies that have improved the reliability and relevance of in-vitro models.

Dermal Toxicity Testing Market - By Type (Product, Service), Testing Method (In Vivo, In Vitro, In Silico Modeling), Test Type (Skin Irritation, Sensitization, & Corrosion, Phototoxicity), End-use (Healthcare, Cosmetics)– Global Forecast 2023-2032

Premium Report Details

Industries

Information

Link

Global Headquarters